Answers are grounded in this paper and cite their sources.
PIEZO1 is a cation channel that is primarily activated through mechanical force, and activation has been shown to be influenced by membrane curvature. PIEZO1 is ubiquitously expressed and plays critical roles in various patho-/physiological processes such as inflammatory diseases or red blood cell volume regulation. Here we combine coarse-grained and atomistic simulations in which human PIEZO1 is embedded in a curved membrane and subjected to simulations under controlled membrane tension and a physiological transmembrane potential, allowing the gating cycle to be reconstructed at atomic resolution. Systematic pressure adaptation identifies an activation regime in which the channel flattens progressively, and ion permeation quantitatively reproduces the experimental conductance of 36 pS. Furthermore, the R2456-E2117 salt bridge couples pore lipid retention to the anchor domain and disrupting it reproduces the phenotypes of the disease-associated R2456H and R2456C variants. PIEZO activation is transmitted through an interconnected network of contact rearrangements that ultimately reshapes the yoda1 binding pocket at the THU8/THU9 interface. This state-dependent remodelling rationalises the pharmacology of yoda1 and offers a framework for the structure-based design of PIEZO1 modulators.
No takes yet. Share an insight, caveat, or question.
Massa et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: